Medigen Biotechnology Corp.
http://www.medigen.com.tw/en/home/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Medigen Biotechnology Corp.
Deal Watch: Organon Obtains Rights To Perjeta, Prolia/Xgeva Biosimilars From Shanghai Henlius
Biosimilar licensing agreement also includes option on Yervoy-based product. Oxford BioTherapeutics, ImmunoGen pair their technologies for development of novel cancer ADCs.
Attorneys Predict Pandemic-Related Rise In False Claims Allegations
The Department of Justice may soon be busy with allegations of pandemic-related fraud and abuse, attorneys predicted in a recent conference presentation.
Exec Chat: Medtronic’s Linnea Burman Targets 'Consensus-Driven Care' Using AI, Robotics In Spine Care
Linnea Burman, the general manager of enabling technologies for cranial and spinal technologies at Medtronic, talked to Medtech Insight about plans for the Mazor spinal robotic system, the incoming new president of the division, and other new developments.
More Candidate COVID-19 Vaccines Expected To Enter WHO’s Global Trial
A new global clinical trial initiative is assessing a number of second-generation candidate vaccines for COVID-19. The Australian medicines regulator has given the go-ahead for an approval application for one of the vaccines, from Taiwan’s Medigen.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
- Other Names / Subsidiaries
-
- Medigen Vaccine Biologics Co.
- Medigen Vaccinology Corp.